Search results for: Policy Analysis
Filter search results
New Methods for Analysing the Distribution of EQ-5D Observations
17 April 2018
…Where the data are used to estimate QALYs, the profile data are summarised using value sets, and the profile data provided by patients is not itself the focus of analysis….
OHE Lecturing for Professional Training at ICPS
5 February 2019
…focusing on case studies for different countries to demonstrate various effects of similar financing and cost-containment policies. The lecture started with the analysis of relevant international studies showing the importance…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
…Figure below, two-thirds of the market by value in low and lower middle-income markets included in CGD’s analysis goes to, almost exclusively, branded generics. Further review of data from a…
Assessing the Life-cycle Value of Second-generation Antipsychotics in Sweden and the UK
17 July 2019
…value is important (Lakdawalla et al., 2017; Puig-Junoy, 2018). It can inform a crucial question for policy makers: how much should society pay for new medicines, in order to reward…
Sleepio: Lessons from the Frontier of Digital Therapeutics
31 May 2022
…January 2020. We designed an interrupted time series analysis, comparing primary care use before and after the rollout of Sleepio, controlling for the trends in resource use before Sleepio was…
Incorporating Multiple Criteria in HTA: Methods and Processes
1 March 2011
What a health care system should pay for depends, of course, on the health gain that results. Health technology assessment (HTA) and cost-effectiveness analysis have become the core for many…
Challenges and Opportunities for Improving Benefit-Risk Assessment of Pharmaceuticals from an Economic Perspective
1 August 2008
…used in economic analysis and the decision sciences might improve the methodologies that… This Briefing reports the discussions of a group of experts at an OHE workshop on the benefit-risk…
Mild Hypertension
1 November 1980
…reading from their prospective clients, and figures derived from their analysis of mortality… The risks from untreated high blood pressure at even mildly elevated levels are well documented in quantitative…
Uses of Models in Economic Evaluations of Medicines and Other Health Technologies
1 October 1996
…decision analysis, he then addresses the need to have information on effectiveness rather than efficacy. Most randomised controlled trials are designed to demonstrate efficacy, whereas decision makers need to know…